diethylnitrosamine has been researched along with metformin in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 4 (57.14) | 2.80 |
| Authors | Studies |
|---|---|
| Baba, A; Kochi, T; Kubota, M; Moriwaki, H; Ohno, T; Shimizu, M; Shirakami, Y; Tanaka, T; Tsurumi, H | 1 |
| Chang, M; Choi, HJ; Jang, JJ; Jang, S; Jo, W; Lee, HJ; Park, HK; Ryu, JE; Son, WC; Yu, ES | 1 |
| Choukimath, SM; Das, BK; Gadad, PC | 1 |
| El-Ahwany, E; El-Kader, EMA; Ghanim, AMH; Saber, S | 1 |
| Khodeer, DM; Mamdouh, AM; Moustafa, YM; Tantawy, MA | 1 |
| Chang, CC; Chang, SH; Ho, HY; Hsu, YH; Lin, MC; Tseng, SH; Wang, DY; Zang, CZ | 1 |
| Dias, F; González Álvarez Tostado, JA; Montiel Maltez, KH; Ponce-Lopez, T | 1 |
7 other study(ies) available for diethylnitrosamine and metformin
| Article | Year |
|---|---|
Metformin suppresses diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BL/KsJ-+Leprdb/+Leprdb mice.
Topics: Adipokines; Animals; Animals, Newborn; Carcinogenesis; Diabetes Mellitus, Experimental; Diethylnitrosamine; Female; Hypoglycemic Agents; Insulin Resistance; Liver; Liver Neoplasms; Male; Metformin; Mice, Inbred C57BL; Mice, Transgenic; Obesity; Oncogene Protein v-akt; Signal Transduction; TOR Serine-Threonine Kinases | 2015 |
Metformin inhibits early stage diethylnitrosamine‑induced hepatocarcinogenesis in rats.
Topics: Adenylate Kinase; Animals; Blotting, Western; Body Weight; Carcinogenesis; Carcinoma, Hepatocellular; Diethylnitrosamine; Glutathione Transferase; Immunohistochemistry; Liver; Liver Neoplasms; Male; Metformin; Neoplasm Staging; Organ Size; Proliferating Cell Nuclear Antigen; Rats, Wistar; Signal Transduction | 2016 |
Asarone and metformin delays experimentally induced hepatocellular carcinoma in diabetic milieu.
Topics: Allylbenzene Derivatives; Animals; Anisoles; Carcinoma, Hepatocellular; Diabetes Mellitus, Experimental; Diethylnitrosamine; Disease Models, Animal; Hyperglycemia; Hypoglycemic Agents; Insulin; Liver; Liver Cirrhosis; Liver Neoplasms; Male; Metformin; Rats; Rats, Wistar | 2019 |
Novel complementary antitumour effects of celastrol and metformin by targeting IκBκB, apoptosis and NLRP3 inflammasome activation in diethylnitrosamine-induced murine hepatocarcinogenesis.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinogenesis; Carcinoma, Hepatocellular; Diethylnitrosamine; I-kappa B Kinase; Inflammasomes; Liver Neoplasms; Male; Metformin; Mice; Mice, Inbred BALB C; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Pentacyclic Triterpenes; Signal Transduction; Triterpenes | 2020 |
In-vitro and in-vivo investigation of amygdalin, metformin, and combination of both against doxorubicin on hepatocellular carcinoma.
Topics: alpha-Fetoproteins; Amygdalin; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Protocols; Biomarkers, Tumor; Carcinoma, Hepatocellular; Diethylnitrosamine; Doxorubicin; Hep G2 Cells; Humans; Liver Neoplasms; Liver Neoplasms, Experimental; Male; Metformin; Prognosis; Rats; Rats, Wistar | 2021 |
Evaluation and optimization of a HS-SPME-assisted GC-MS/MS method for monitoring nitrosamine impurities in diverse pharmaceuticals.
Topics: Angiotensin II Type 1 Receptor Blockers; Diethylnitrosamine; Dimethylnitrosamine; Gas Chromatography-Mass Spectrometry; Metformin; Nitrosamines; Pharmaceutical Preparations; Ranitidine; Sodium Chloride; Solid Phase Microextraction; Tandem Mass Spectrometry | 2022 |
Metformin Prevents NDEA-Induced Memory Impairments Associated with Attenuating Beta-Amyloid, Tumor Necrosis Factor-Alpha, and Interleukin-6 Levels in the Hippocampus of Rats.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Carcinogens; Cytokines; Diethylnitrosamine; Hippocampus; Interleukin-6; Memory Disorders; Metformin; NF-kappa B; Phosphatidylinositol 3-Kinases; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha | 2023 |